Envestnet Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,016
Closed -$104K 4432
2024
Q4
$104K Sell
19,016
-23,677
-55% -$152K ﹤0.01% 4206
2024
Q3
$355K Sell
42,693
-7,540
-15% -$65.2K ﹤0.01% 3724
2024
Q2
$360K Sell
50,233
-2,458
-5% -$21.2K ﹤0.01% 3626
2024
Q1
$457K Buy
52,691
+17,948
+52% +$121K ﹤0.01% 3498
2023
Q4
$228K Sell
34,743
-42,612
-55% -$275K ﹤0.01% 3763
2023
Q3
$774K Buy
77,355
+10,193
+15% +$112K ﹤0.01% 2999
2023
Q2
$835K Sell
67,162
-77,494
-54% -$1.05M ﹤0.01% 2874
2023
Q1
$658K Buy
144,656
+116,329
+411% +$1.67M ﹤0.01% 2965
2022
Q4
$405K Sell
28,327
-6,002
-17% -$94.5K ﹤0.01% 3221
2022
Q3
$876K Sell
34,329
-14,526
-30% -$364K ﹤0.01% 2677
2022
Q2
$1.39M Buy
48,855
+22,472
+85% +$712K ﹤0.01% 2350
2022
Q1
$931K Buy
26,383
+1,107
+4% +$37.1K ﹤0.01% 2719
2021
Q4
$1.06M Buy
25,276
+10,208
+68% +$414K ﹤0.01% 2596
2021
Q3
$740K Buy
15,068
+1,177
+8% +$57.4K ﹤0.01% 2734
2021
Q2
$580K Buy
13,891
+4,519
+48% +$175K ﹤0.01% 2884
2021
Q1
$334K Buy
9,372
+1,111
+13% +$36.8K ﹤0.01% 3078
2020
Q4
$232K Buy
+8,261
New +$230K ﹤0.01% 3057

Other funds holding MRVI

Envestnet Asset Management's MRVI Position: Q1 2025 in Review

Envestnet Asset Management sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 19,016 shares — an estimated $104K sold.

Envestnet Asset Management first reported a position in MRVI in Q4 2020 and held it in 17 quarters. The position peaked at $1.39M in Q2 2022. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • Envestnet Asset Management reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 19,016 Maravai LifeSciences shares in Q1 2025, an estimated $104K.
  • Envestnet Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 17 quarters.
  • Envestnet Asset Management's Maravai LifeSciences position peaked at $1.39M in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Envestnet Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.